TLOG (TetraLogic Pharmaceuticals) ROCE %: -107.20% (As of Sep. 2016)


What is TetraLogic Pharmaceuticals ROCE %?

TetraLogic Pharmaceuticals TLOG ROCE % is -107.20% as of Sep. 2016.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. TetraLogic Pharmaceuticals's annualized ROCE % for the quarter that ended in Sep. 2016 was -107.20%.

TetraLogic Pharmaceuticals  (OTCPK:TLOG) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

TetraLogic Pharmaceuticals ROCE % Related Terms

TetraLogic Pharmaceuticals ROCE % Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals ROCE % Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
ROCE %
-147.08 -220.57 -65.67 -40.23 -50.44

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -41.03 -68.21 -66.46 -43.84 -107.20

TetraLogic Pharmaceuticals ROCE % Calculation

TetraLogic Pharmaceuticals's annualized ROCE % for the fiscal year that ended in Dec. 2015 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2015 )  (A: Dec. 2014 )(A: Dec. 2015 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2015 )  (A: Dec. 2014 )(A: Dec. 2015 )
=-43.34/( ( (116.616 - 5.122) + (64.021 - 3.66) )/ 2 )
=-43.34/( (111.494+60.361)/ 2 )
=-43.34/85.9275
=-50.44 %

TetraLogic Pharmaceuticals's ROCE % of for the quarter that ended in Sep. 2016 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2016 )  (Q: Jun. 2016 )(Q: Sep. 2016 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2016 )  (Q: Jun. 2016 )(Q: Sep. 2016 )
=-36.772/( ( (51.057 - 11.905) + (42.788 - 13.334) )/ 2 )
=-36.772/( ( 39.152 + 29.454 )/ 2 )
=-36.772/34.303
=-107.20 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2016) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -107.20% mean?
TetraLogic Pharmaceuticals (TLOG) has a ROCE % of -107.20% as of Sep. 2016.
Is TetraLogic Pharmaceuticals' ROCE % too high?
TetraLogic Pharmaceuticals' current ROCE % is -107.20%.
How does TetraLogic Pharmaceuticals' ROCE % compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' ROCE % of -107.20% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. TetraLogic Pharmaceuticals's current ROCE % is -107.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current ROCE % of -107.20%. The current ROCE % is -107.20%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current ROCE % is -107.20% as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.